Enzyme Receptor mRNA

product-img

Introduction Product List Product FeaturesApplication Q&A

Introduction

The enzyme receptor is a kind of transmembrane protein that functions as both a receptor and an enzyme catalyst, acting mainly by forming homo- or heterodimers. Once activated by a ligand, the enzyme receptor will become enzymatically active and amplify the signal, which is also known as catalytic receptor. Creative Biolabs offers you various of mRNA products corresponding to more than 20 enzyme receptors, all of which are of high quality and purity synthesized on the IVTScrip™ platform. You can choose from different specifications of enzyme receptor mRNA according to your needs, including nucleoside modification groups, length of the 3'-terminal poly(A) tail and the type of cap addition at the 5' end. The enzyme receptor mRNA products are mainly used in the study of signaling mechanisms of different types of enzyme receptors and related investigations in the field of gene therapy.

In addition to the pre-products shown in the mRNA product list, Creative Biolabs also offers customized enzyme receptor mRNAs via the IVTScrip™ platform. After your customization requirements are confirmed, mRNA customization service will revolve around template design, optimization of the synthesis strategy and validation of the various stages of the synthesis process. For each customization part, our experts will provide you with a detailed design proposal. Creative Biolabs' customization service has always been aimed at providing you with optimal mRNA stability and translation efficiency. If you are interested in our products, please feel free to contact us.

Product List

>>>Can't find what your looking for? Contact us and we will be happy to help.

Product Features

Strict Quality Control Standards
- Multiple quality control standards.
- High stability and batch-to-batch consistency.
- Excellent purity and stability profile.
Efficient and Time-saving
- Pre-designed capping and poly (A) tail modification.
- Shorter turnaround time.

Application

Gene Therapy: Enzyme receptor mRNA has applications in gene therapy, where mRNA molecules are used to express therapeutic proteins within the body. This approach can be used to correct genetic disorders by introducing mRNA that encodes for the functional enzyme or receptor that is missing or defective in patients. Unlike traditional gene therapy that involves permanent changes to the DNA, mRNA-based therapies are temporary and considered safer, as they do not integrate into the genome, reducing the risk of insertional mutagenesis.
Gene Therapy: Enzyme receptor mRNA has applications in gene therapy, where mRNA molecules are used to express therapeutic proteins within the body. This approach can be used to correct genetic disorders by introducing mRNA that encodes for the functional enzyme or receptor that is missing or defective in patients. Unlike traditional gene therapy that involves permanent changes to the DNA, mRNA-based therapies are temporary and considered safer, as they do not integrate into the genome, reducing the risk of insertional mutagenesis.
Gene Therapy: Enzyme receptor mRNA has applications in gene therapy, where mRNA molecules are used to express therapeutic proteins within the body. This approach can be used to correct genetic disorders by introducing mRNA that encodes for the functional enzyme or receptor that is missing or defective in patients. Unlike traditional gene therapy that involves permanent changes to the DNA, mRNA-based therapies are temporary and considered safer, as they do not integrate into the genome, reducing the risk of insertional mutagenesis.
Gene Therapy: Enzyme receptor mRNA has applications in gene therapy, where mRNA molecules are used to express therapeutic proteins within the body. This approach can be used to correct genetic disorders by introducing mRNA that encodes for the functional enzyme or receptor that is missing or defective in patients. Unlike traditional gene therapy that involves permanent changes to the DNA, mRNA-based therapies are temporary and considered safer, as they do not integrate into the genome, reducing the risk of insertional mutagenesis.

Q&A

Q: What is the best method to inhibit the expression of a specific enzyme receptor mRNA in cells?

A: RNA interference (RNAi) using small interfering RNAs (siRNAs) or short hairpin RNAs (shRNAs) is commonly used to specifically downregulate the expression of target mRNA. CRISPR-Cas9 technology can also be adapted to repress mRNA expression by targeting the DNA sequence encoding the mRNA, leading to gene editing or transcriptional repression.

Q: How can the effect of environmental factors on the expression of enzyme receptor mRNA be studied?

A: Environmental factors can be simulated in cell culture or animal models, followed by measuring the changes in mRNA expression levels using qPCR or RNA-seq. Controlled experiments can vary the exposure in terms of type, concentration, and duration to assess the impact on mRNA expression.

Q: How can we predict the secondary structure of enzyme receptor mRNA and its significance?

A: Bioinformatics tools like Mfold or RNAfold can predict mRNA secondary structure based on nucleotide sequence. The structure can affect mRNA stability, translation efficiency, and interaction with regulatory proteins and RNAs, impacting the receptor's expression and function.

Q: Can the stability of enzyme receptor mRNA be artificially manipulated, and how?

A: Yes, the stability can be manipulated by modifying the mRNA's untranslated regions (UTRs) or by using stabilizing or destabilizing elements. For example, adding AU-rich elements (AREs) in the 3' UTR can decrease stability, whereas removing them or adding stabilizing sequences like the beta-globin 3' UTR can increase stability.

Q: What strategies can be employed to enhance the delivery and expression of therapeutic enzyme receptor mRNA in vivo?

A: Strategies include using viral vectors for efficient cell entry, optimizing mRNA sequences for stability and translational efficiency, encapsulating mRNA in lipid nanoparticles to protect it from degradation and facilitate cellular uptake, and targeting specific tissues or cells with ligands or antibodies.

Q: How can computational modeling be used to predict the function of novel enzyme receptor mRNAs?

A: Computational modeling can predict mRNA structure, potential protein interactions, and impact on signaling pathways based on sequence analysis and comparison to known mRNAs. Molecular docking simulations can predict how the encoded protein might interact with ligands or other proteins, providing insights into its potential function.

IVTScrip™ mRNA-Human CD201, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) (CAT#: GTTS-WK0067MR)

Product type mRNA

Transcript CD201

Category (CDS) Enzyme Receptor

Applications Gene therapy research